Myotonic Dystrophy Type 1 (DM1) Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Myotonic Dystrophy Type 1 (DM1) in global, including the following market information:
Global Myotonic Dystrophy Type 1 (DM1) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Myotonic Dystrophy Type 1 (DM1) Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Myotonic Dystrophy Type 1 (DM1) companies in 2021 (%)
The global Myotonic Dystrophy Type 1 (DM1) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Exondys Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Myotonic Dystrophy Type 1 (DM1) include Dyne, Audentes, Pfizer, Vertex, PepGen, NeuBase Therapeutics, Lupin, AMO Pharma and Expansion Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Myotonic Dystrophy Type 1 (DM1) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Myotonic Dystrophy Type 1 (DM1) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Myotonic Dystrophy Type 1 (DM1) Market Segment Percentages, by Type, 2021 (%)
Global Myotonic Dystrophy Type 1 (DM1) Market Segment Percentages, by Application, 2021 (%)
Global Myotonic Dystrophy Type 1 (DM1) Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Myotonic Dystrophy Type 1 (DM1) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Myotonic Dystrophy Type 1 (DM1) revenues share in global market, 2021 (%)
Key companies Myotonic Dystrophy Type 1 (DM1) sales in global market, 2017-2022 (Estimated), (Units)
Key companies Myotonic Dystrophy Type 1 (DM1) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Myotonic Dystrophy Type 1 (DM1) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Myotonic Dystrophy Type 1 (DM1) Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Myotonic Dystrophy Type 1 (DM1) companies in 2021 (%)
The global Myotonic Dystrophy Type 1 (DM1) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Exondys Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Myotonic Dystrophy Type 1 (DM1) include Dyne, Audentes, Pfizer, Vertex, PepGen, NeuBase Therapeutics, Lupin, AMO Pharma and Expansion Therapeutics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Myotonic Dystrophy Type 1 (DM1) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Myotonic Dystrophy Type 1 (DM1) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Myotonic Dystrophy Type 1 (DM1) Market Segment Percentages, by Type, 2021 (%)
- Exondys
- Emflaza
- Translarna
Global Myotonic Dystrophy Type 1 (DM1) Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Clinics
- Home Care
Global Myotonic Dystrophy Type 1 (DM1) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Myotonic Dystrophy Type 1 (DM1) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Myotonic Dystrophy Type 1 (DM1) revenues share in global market, 2021 (%)
Key companies Myotonic Dystrophy Type 1 (DM1) sales in global market, 2017-2022 (Estimated), (Units)
Key companies Myotonic Dystrophy Type 1 (DM1) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Dyne
- Audentes
- Pfizer
- Vertex
- PepGen
- NeuBase Therapeutics
- Lupin
- AMO Pharma
- Expansion Therapeutics
- Harmony Biosciences
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Myotonic Dystrophy Type 1 (DM1) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Myotonic Dystrophy Type 1 (DM1) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MYOTONIC DYSTROPHY TYPE 1 (DM1) OVERALL MARKET SIZE
2.1 Global Myotonic Dystrophy Type 1 (DM1) Market Size: 2021 VS 2028
2.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Myotonic Dystrophy Type 1 (DM1) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Myotonic Dystrophy Type 1 (DM1) Players in Global Market
3.2 Top Global Myotonic Dystrophy Type 1 (DM1) Companies Ranked by Revenue
3.3 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Companies
3.4 Global Myotonic Dystrophy Type 1 (DM1) Sales by Companies
3.5 Global Myotonic Dystrophy Type 1 (DM1) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Myotonic Dystrophy Type 1 (DM1) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Myotonic Dystrophy Type 1 (DM1) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Myotonic Dystrophy Type 1 (DM1) Players in Global Market
3.8.1 List of Global Tier 1 Myotonic Dystrophy Type 1 (DM1) Companies
3.8.2 List of Global Tier 2 and Tier 3 Myotonic Dystrophy Type 1 (DM1) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Myotonic Dystrophy Type 1 (DM1) Market Size Markets, 2021 & 2028
4.1.2 Exondys
4.1.3 Emflaza
4.1.4 Translarna
4.2 By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue & Forecasts
4.2.1 By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2022
4.2.2 By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2023-2028
4.2.3 By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
4.3 By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales & Forecasts
4.3.1 By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2022
4.3.2 By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales, 2023-2028
4.3.3 By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
4.4 By Type - Global Myotonic Dystrophy Type 1 (DM1) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Myotonic Dystrophy Type 1 (DM1) Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Home Care
5.2 By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue & Forecasts
5.2.1 By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2022
5.2.2 By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2023-2028
5.2.3 By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
5.3 By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales & Forecasts
5.3.1 By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2022
5.3.2 By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales, 2023-2028
5.3.3 By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
5.4 By Application - Global Myotonic Dystrophy Type 1 (DM1) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Myotonic Dystrophy Type 1 (DM1) Market Size, 2021 & 2028
6.2 By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue & Forecasts
6.2.1 By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2022
6.2.2 By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2023-2028
6.2.3 By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
6.3 By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales & Forecasts
6.3.1 By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2022
6.3.2 By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales, 2023-2028
6.3.3 By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2028
6.4.2 By Country - North America Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2028
6.4.3 US Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.4.4 Canada Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.4.5 Mexico Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2028
6.5.2 By Country - Europe Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2028
6.5.3 Germany Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5.4 France Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5.5 U.K. Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5.6 Italy Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5.7 Russia Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5.8 Nordic Countries Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5.9 Benelux Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2028
6.6.2 By Region - Asia Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2028
6.6.3 China Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.6.4 Japan Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.6.5 South Korea Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.6.6 Southeast Asia Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.6.7 India Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2028
6.7.2 By Country - South America Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2028
6.7.3 Brazil Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.7.4 Argentina Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2028
6.8.3 Turkey Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.8.4 Israel Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.8.5 Saudi Arabia Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.8.6 UAE Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Dyne
7.1.1 Dyne Corporate Summary
7.1.2 Dyne Business Overview
7.1.3 Dyne Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.1.4 Dyne Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.1.5 Dyne Key News
7.2 Audentes
7.2.1 Audentes Corporate Summary
7.2.2 Audentes Business Overview
7.2.3 Audentes Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.2.4 Audentes Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.2.5 Audentes Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.3.4 Pfizer Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Vertex
7.4.1 Vertex Corporate Summary
7.4.2 Vertex Business Overview
7.4.3 Vertex Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.4.4 Vertex Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.4.5 Vertex Key News
7.5 PepGen
7.5.1 PepGen Corporate Summary
7.5.2 PepGen Business Overview
7.5.3 PepGen Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.5.4 PepGen Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.5.5 PepGen Key News
7.6 NeuBase Therapeutics
7.6.1 NeuBase Therapeutics Corporate Summary
7.6.2 NeuBase Therapeutics Business Overview
7.6.3 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.6.4 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.6.5 NeuBase Therapeutics Key News
7.7 Lupin
7.7.1 Lupin Corporate Summary
7.7.2 Lupin Business Overview
7.7.3 Lupin Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.7.4 Lupin Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.7.5 Lupin Key News
7.8 AMO Pharma
7.8.1 AMO Pharma Corporate Summary
7.8.2 AMO Pharma Business Overview
7.8.3 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.8.4 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.8.5 AMO Pharma Key News
7.9 Expansion Therapeutics
7.9.1 Expansion Therapeutics Corporate Summary
7.9.2 Expansion Therapeutics Business Overview
7.9.3 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.9.4 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.9.5 Expansion Therapeutics Key News
7.10 Harmony Biosciences
7.10.1 Harmony Biosciences Corporate Summary
7.10.2 Harmony Biosciences Business Overview
7.10.3 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.10.4 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.10.5 Harmony Biosciences Key News
8 GLOBAL MYOTONIC DYSTROPHY TYPE 1 (DM1) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Myotonic Dystrophy Type 1 (DM1) Production Capacity, 2017-2028
8.2 Myotonic Dystrophy Type 1 (DM1) Production Capacity of Key Manufacturers in Global Market
8.3 Global Myotonic Dystrophy Type 1 (DM1) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 MYOTONIC DYSTROPHY TYPE 1 (DM1) SUPPLY CHAIN ANALYSIS
10.1 Myotonic Dystrophy Type 1 (DM1) Industry Value Chain
10.2 Myotonic Dystrophy Type 1 (DM1) Upstream Market
10.3 Myotonic Dystrophy Type 1 (DM1) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Myotonic Dystrophy Type 1 (DM1) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Myotonic Dystrophy Type 1 (DM1) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Myotonic Dystrophy Type 1 (DM1) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MYOTONIC DYSTROPHY TYPE 1 (DM1) OVERALL MARKET SIZE
2.1 Global Myotonic Dystrophy Type 1 (DM1) Market Size: 2021 VS 2028
2.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Myotonic Dystrophy Type 1 (DM1) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Myotonic Dystrophy Type 1 (DM1) Players in Global Market
3.2 Top Global Myotonic Dystrophy Type 1 (DM1) Companies Ranked by Revenue
3.3 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Companies
3.4 Global Myotonic Dystrophy Type 1 (DM1) Sales by Companies
3.5 Global Myotonic Dystrophy Type 1 (DM1) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Myotonic Dystrophy Type 1 (DM1) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Myotonic Dystrophy Type 1 (DM1) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Myotonic Dystrophy Type 1 (DM1) Players in Global Market
3.8.1 List of Global Tier 1 Myotonic Dystrophy Type 1 (DM1) Companies
3.8.2 List of Global Tier 2 and Tier 3 Myotonic Dystrophy Type 1 (DM1) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Myotonic Dystrophy Type 1 (DM1) Market Size Markets, 2021 & 2028
4.1.2 Exondys
4.1.3 Emflaza
4.1.4 Translarna
4.2 By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue & Forecasts
4.2.1 By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2022
4.2.2 By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2023-2028
4.2.3 By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
4.3 By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales & Forecasts
4.3.1 By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2022
4.3.2 By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales, 2023-2028
4.3.3 By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
4.4 By Type - Global Myotonic Dystrophy Type 1 (DM1) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Myotonic Dystrophy Type 1 (DM1) Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Home Care
5.2 By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue & Forecasts
5.2.1 By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2022
5.2.2 By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2023-2028
5.2.3 By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
5.3 By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales & Forecasts
5.3.1 By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2022
5.3.2 By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales, 2023-2028
5.3.3 By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
5.4 By Application - Global Myotonic Dystrophy Type 1 (DM1) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Myotonic Dystrophy Type 1 (DM1) Market Size, 2021 & 2028
6.2 By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue & Forecasts
6.2.1 By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2022
6.2.2 By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2023-2028
6.2.3 By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
6.3 By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales & Forecasts
6.3.1 By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2022
6.3.2 By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales, 2023-2028
6.3.3 By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2028
6.4.2 By Country - North America Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2028
6.4.3 US Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.4.4 Canada Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.4.5 Mexico Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2028
6.5.2 By Country - Europe Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2028
6.5.3 Germany Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5.4 France Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5.5 U.K. Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5.6 Italy Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5.7 Russia Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5.8 Nordic Countries Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.5.9 Benelux Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2028
6.6.2 By Region - Asia Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2028
6.6.3 China Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.6.4 Japan Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.6.5 South Korea Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.6.6 Southeast Asia Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.6.7 India Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2028
6.7.2 By Country - South America Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2028
6.7.3 Brazil Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.7.4 Argentina Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales, 2017-2028
6.8.3 Turkey Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.8.4 Israel Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.8.5 Saudi Arabia Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
6.8.6 UAE Myotonic Dystrophy Type 1 (DM1) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Dyne
7.1.1 Dyne Corporate Summary
7.1.2 Dyne Business Overview
7.1.3 Dyne Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.1.4 Dyne Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.1.5 Dyne Key News
7.2 Audentes
7.2.1 Audentes Corporate Summary
7.2.2 Audentes Business Overview
7.2.3 Audentes Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.2.4 Audentes Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.2.5 Audentes Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.3.4 Pfizer Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Vertex
7.4.1 Vertex Corporate Summary
7.4.2 Vertex Business Overview
7.4.3 Vertex Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.4.4 Vertex Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.4.5 Vertex Key News
7.5 PepGen
7.5.1 PepGen Corporate Summary
7.5.2 PepGen Business Overview
7.5.3 PepGen Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.5.4 PepGen Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.5.5 PepGen Key News
7.6 NeuBase Therapeutics
7.6.1 NeuBase Therapeutics Corporate Summary
7.6.2 NeuBase Therapeutics Business Overview
7.6.3 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.6.4 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.6.5 NeuBase Therapeutics Key News
7.7 Lupin
7.7.1 Lupin Corporate Summary
7.7.2 Lupin Business Overview
7.7.3 Lupin Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.7.4 Lupin Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.7.5 Lupin Key News
7.8 AMO Pharma
7.8.1 AMO Pharma Corporate Summary
7.8.2 AMO Pharma Business Overview
7.8.3 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.8.4 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.8.5 AMO Pharma Key News
7.9 Expansion Therapeutics
7.9.1 Expansion Therapeutics Corporate Summary
7.9.2 Expansion Therapeutics Business Overview
7.9.3 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.9.4 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.9.5 Expansion Therapeutics Key News
7.10 Harmony Biosciences
7.10.1 Harmony Biosciences Corporate Summary
7.10.2 Harmony Biosciences Business Overview
7.10.3 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.10.4 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2017-2022)
7.10.5 Harmony Biosciences Key News
8 GLOBAL MYOTONIC DYSTROPHY TYPE 1 (DM1) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Myotonic Dystrophy Type 1 (DM1) Production Capacity, 2017-2028
8.2 Myotonic Dystrophy Type 1 (DM1) Production Capacity of Key Manufacturers in Global Market
8.3 Global Myotonic Dystrophy Type 1 (DM1) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 MYOTONIC DYSTROPHY TYPE 1 (DM1) SUPPLY CHAIN ANALYSIS
10.1 Myotonic Dystrophy Type 1 (DM1) Industry Value Chain
10.2 Myotonic Dystrophy Type 1 (DM1) Upstream Market
10.3 Myotonic Dystrophy Type 1 (DM1) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Myotonic Dystrophy Type 1 (DM1) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Myotonic Dystrophy Type 1 (DM1) in Global Market
Table 2. Top Myotonic Dystrophy Type 1 (DM1) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Myotonic Dystrophy Type 1 (DM1) Revenue Share by Companies, 2017-2022
Table 5. Global Myotonic Dystrophy Type 1 (DM1) Sales by Companies, (Units), 2017-2022
Table 6. Global Myotonic Dystrophy Type 1 (DM1) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Myotonic Dystrophy Type 1 (DM1) Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Myotonic Dystrophy Type 1 (DM1) Product Type
Table 9. List of Global Tier 1 Myotonic Dystrophy Type 1 (DM1) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Myotonic Dystrophy Type 1 (DM1) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2017-2022
Table 15. By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2023-2028
Table 16. By Application – Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2017-2022
Table 20. By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2023-2028
Table 21. By Region – Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2017-2022
Table 25. By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2023-2028
Table 26. By Country - North America Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2017-2022
Table 29. By Country - North America Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2023-2028
Table 30. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2017-2022
Table 33. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2023-2028
Table 34. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2017-2022
Table 37. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2023-2028
Table 38. By Country - South America Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2017-2022
Table 41. By Country - South America Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2023-2028
Table 46. Dyne Corporate Summary
Table 47. Dyne Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 48. Dyne Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Audentes Corporate Summary
Table 50. Audentes Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 51. Audentes Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 54. Pfizer Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Vertex Corporate Summary
Table 56. Vertex Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 57. Vertex Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. PepGen Corporate Summary
Table 59. PepGen Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 60. PepGen Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. NeuBase Therapeutics Corporate Summary
Table 62. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 63. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Lupin Corporate Summary
Table 65. Lupin Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 66. Lupin Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. AMO Pharma Corporate Summary
Table 68. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 69. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Expansion Therapeutics Corporate Summary
Table 71. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 72. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Harmony Biosciences Corporate Summary
Table 74. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 75. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Myotonic Dystrophy Type 1 (DM1) Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 77. Global Myotonic Dystrophy Type 1 (DM1) Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Myotonic Dystrophy Type 1 (DM1) Production by Region, 2017-2022 (Units)
Table 79. Global Myotonic Dystrophy Type 1 (DM1) Production by Region, 2023-2028 (Units)
Table 80. Myotonic Dystrophy Type 1 (DM1) Market Opportunities & Trends in Global Market
Table 81. Myotonic Dystrophy Type 1 (DM1) Market Drivers in Global Market
Table 82. Myotonic Dystrophy Type 1 (DM1) Market Restraints in Global Market
Table 83. Myotonic Dystrophy Type 1 (DM1) Raw Materials
Table 84. Myotonic Dystrophy Type 1 (DM1) Raw Materials Suppliers in Global Market
Table 85. Typical Myotonic Dystrophy Type 1 (DM1) Downstream
Table 86. Myotonic Dystrophy Type 1 (DM1) Downstream Clients in Global Market
Table 87. Myotonic Dystrophy Type 1 (DM1) Distributors and Sales Agents in Global Market
Table 1. Key Players of Myotonic Dystrophy Type 1 (DM1) in Global Market
Table 2. Top Myotonic Dystrophy Type 1 (DM1) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Myotonic Dystrophy Type 1 (DM1) Revenue Share by Companies, 2017-2022
Table 5. Global Myotonic Dystrophy Type 1 (DM1) Sales by Companies, (Units), 2017-2022
Table 6. Global Myotonic Dystrophy Type 1 (DM1) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Myotonic Dystrophy Type 1 (DM1) Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Myotonic Dystrophy Type 1 (DM1) Product Type
Table 9. List of Global Tier 1 Myotonic Dystrophy Type 1 (DM1) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Myotonic Dystrophy Type 1 (DM1) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2017-2022
Table 15. By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2023-2028
Table 16. By Application – Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2017-2022
Table 20. By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2023-2028
Table 21. By Region – Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2017-2022
Table 25. By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2023-2028
Table 26. By Country - North America Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2017-2022
Table 29. By Country - North America Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2023-2028
Table 30. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2017-2022
Table 33. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2023-2028
Table 34. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2017-2022
Table 37. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2023-2028
Table 38. By Country - South America Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2017-2022
Table 41. By Country - South America Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2023-2028
Table 42. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2017-2022
Table 45. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2023-2028
Table 46. Dyne Corporate Summary
Table 47. Dyne Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 48. Dyne Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Audentes Corporate Summary
Table 50. Audentes Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 51. Audentes Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 54. Pfizer Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Vertex Corporate Summary
Table 56. Vertex Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 57. Vertex Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. PepGen Corporate Summary
Table 59. PepGen Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 60. PepGen Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. NeuBase Therapeutics Corporate Summary
Table 62. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 63. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Lupin Corporate Summary
Table 65. Lupin Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 66. Lupin Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. AMO Pharma Corporate Summary
Table 68. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 69. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Expansion Therapeutics Corporate Summary
Table 71. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 72. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Harmony Biosciences Corporate Summary
Table 74. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 75. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Myotonic Dystrophy Type 1 (DM1) Production Capacity (Units) of Key Manufacturers in Global Market, 2020-2022 (Units)
Table 77. Global Myotonic Dystrophy Type 1 (DM1) Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Myotonic Dystrophy Type 1 (DM1) Production by Region, 2017-2022 (Units)
Table 79. Global Myotonic Dystrophy Type 1 (DM1) Production by Region, 2023-2028 (Units)
Table 80. Myotonic Dystrophy Type 1 (DM1) Market Opportunities & Trends in Global Market
Table 81. Myotonic Dystrophy Type 1 (DM1) Market Drivers in Global Market
Table 82. Myotonic Dystrophy Type 1 (DM1) Market Restraints in Global Market
Table 83. Myotonic Dystrophy Type 1 (DM1) Raw Materials
Table 84. Myotonic Dystrophy Type 1 (DM1) Raw Materials Suppliers in Global Market
Table 85. Typical Myotonic Dystrophy Type 1 (DM1) Downstream
Table 86. Myotonic Dystrophy Type 1 (DM1) Downstream Clients in Global Market
Table 87. Myotonic Dystrophy Type 1 (DM1) Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Myotonic Dystrophy Type 1 (DM1) Segment by Type
Figure 2. Myotonic Dystrophy Type 1 (DM1) Segment by Application
Figure 3. Global Myotonic Dystrophy Type 1 (DM1) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Myotonic Dystrophy Type 1 (DM1) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2028 (US$, Mn)
Figure 7. Myotonic Dystrophy Type 1 (DM1) Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Myotonic Dystrophy Type 1 (DM1) Revenue in 2021
Figure 9. By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 10. By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Myotonic Dystrophy Type 1 (DM1) Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 13. By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Myotonic Dystrophy Type 1 (DM1) Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 16. By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 19. US Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 24. Germany Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 25. France Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 33. China Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 37. India Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 40. Brazil Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 44. Turkey Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Myotonic Dystrophy Type 1 (DM1) Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Myotonic Dystrophy Type 1 (DM1) by Region, 2021 VS 2028
Figure 50. Myotonic Dystrophy Type 1 (DM1) Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Myotonic Dystrophy Type 1 (DM1) Segment by Type
Figure 2. Myotonic Dystrophy Type 1 (DM1) Segment by Application
Figure 3. Global Myotonic Dystrophy Type 1 (DM1) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Myotonic Dystrophy Type 1 (DM1) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2017-2028 (US$, Mn)
Figure 7. Myotonic Dystrophy Type 1 (DM1) Sales in Global Market: 2017-2028 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Myotonic Dystrophy Type 1 (DM1) Revenue in 2021
Figure 9. By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 10. By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Myotonic Dystrophy Type 1 (DM1) Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 13. By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Myotonic Dystrophy Type 1 (DM1) Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 16. By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 19. US Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 24. Germany Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 25. France Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 33. China Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 37. India Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 40. Brazil Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2017-2028
Figure 44. Turkey Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Myotonic Dystrophy Type 1 (DM1) Production Capacity (Units), 2017-2028
Figure 49. The Percentage of Production Myotonic Dystrophy Type 1 (DM1) by Region, 2021 VS 2028
Figure 50. Myotonic Dystrophy Type 1 (DM1) Industry Value Chain
Figure 51. Marketing Channels
